Improvement of Troublesome Dyskinesia in People with Parkinson’s Disease Treated with Foslevodopa/Foscarbidopa (P7-5.032)

Authors

Morten Blaabjerg (ORCID: https://orcid.org/0000-0001-6007-1861)
Elizabeth Peckham
Tsao‐Wei Liang
Lars Bergmann (ORCID: https://orcid.org/0000-0002-8603-8549)
S. Elizabeth Zauber (ORCID: https://orcid.org/0000-0001-9003-4666)
Resmi Gupta (ORCID: https://orcid.org/0000-0001-6552-4372)
Megha Shah
Linda Harmer
Filip Bergquist

Institutions

Thomas Jefferson University (US)
Sahlgrenska University Hospital (SE)
Odense University Hospital (DK)
AbbVie (United States) (US)
Central Texas Neurology Consultants (US)
University School (US)
AbbVie (Japan)
Indiana University School of Medicine
Indiana University (US)
University of Gothenburg (SE)

Publication Details

Journal: Neurology
Published: 2025-04-07
DOI: https://doi.org/10.1212/wnl.0000000000210696
Citations: 2
Primary Topic: Parkinson's Disease Mechanisms and Treatments
Type: article
Field-Weighted Citation Impact: 2.78

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Improvement of Troublesome Dyskinesia in People with Parkinson’s Disease Treated with Foslevodopa/Foscarbidopa (P7-5.032)

Morten Blaabjerg, Elizabeth Peckham, Tsao‐Wei Liang, Lars Bergmann et al.

Apr 7, 2025

2 citations

Neurology

Parkinson's Disease Mechanisms and Treatments

2.78

article

Improvement of Troublesome Dyskinesia in People with Parkinson’s Disease Treated with Foslevodopa/Foscarbidopa (P7-5.032)

Morten Blaabjerg, Elizabeth Peckham, Tsao‐Wei Liang, Lars Bergmann, S. Elizabeth Zauber, Resmi Gupta, Megha Shah, Linda Harmer, Filip Bergquist

April 7, 2025article en

2 citations

Abstract

No abstract available for this paper.

NeurologyVol. 104(7_Supplement_1)

Thomas Jefferson University (US), Sahlgrenska University Hospital (SE), Odense University Hospital (DK), AbbVie (United States) (US), Central Texas Neurology Consultants (US), University School (US), AbbVie (Japan), Indiana University School of Medicine, Indiana University (US), University of Gothenburg (SE)

Openalex Percentile: Top 11%

Parkinson's Disease Mechanisms and Treatments

2.78

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Improvement of Troublesome Dyskinesia in People with Parkinson’s Disease Treated with Foslevodopa/Foscarbidopa (P7-5.032) — Morten Blaabjerg, Elizabeth Peckham, et al. · Neurology (2025) | TGRS Research Map | TGRS